LBA02-12 A MULTICENTER PHASE 3 STUDY OF PSMA-TARGETED 18 F-DCFPYL PET/CT IN MEN WITH BIOCHEMICALLY RECURRENT PROSTATE CANCER: RESULTS FROM THE CONDOR TRIAL

Michael A. Gorin,Barry A. Siegel,Steven P. Rowe,Lawrence Saperstein,Frédéric Pouliot,David Y. Josephson,Jeffrey Y.C. Wong,Austin R. Pantel,Steve Cho,Kenneth L. Gage,Morand Piert,Andrei Iagaru,Janet H. Pollard,Vivien Wong,Jessica Jensen,Nancy Stambler,Michael J. Morris,Peter Carroll

The Journal of Urology（2020）

引用 0|浏览86

暂无评分

摘要

Introduction:Improved diagnostics are needed to better inform the treatment of men with biochemically recurrent (BCR) prostate cancer (PCa). 18F-DCFPyL is a novel PET agent that selectively binds w...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要